瑞舒伐他汀对2型糖尿病患者的血脂及血管内皮功能的影响

来源 :药物流行病学杂志 | 被引量 : 0次 | 上传用户:xinyi
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨瑞舒伐他汀对2型糖尿病患者的血脂及血清血管性血友病因子(vWF)、凝血酶调节蛋白(TM)水平的影响。方法:80例2型糖尿病患者随机分为观察组和对照组。两组患者均在饮食调整、适当体育锻炼基础上予以口服降糖药或胰岛素注射治疗。观察组患者加用瑞舒伐他汀片10 mg,po qd,连用12周。比较两组患者治疗前后血脂、血清vWF和TM水平变化及药品不良反应。结果:治疗12周后,观察组总胆固醇(TC)、三酰甘油(TG)和低密度脂蛋白胆固醇(LDL-C)水平均有不同程度下降,高密度脂蛋白胆固醇(HDL-C)水平明显上升(P<0.05);而对照组治疗前后TC、TG、LDL-C和HDL-C水平变化不明显(P>0.05);两组患者血清vWF和TM水平均有不同程度下降(P<0.05或0.01),且观察组下降幅度较对照组更明显(P<0.05)。两组患者治疗中未见明显药品不良反应。结论:瑞舒伐他汀能调节2型糖尿病患者的血脂代谢紊乱,安全性较佳,并能降低患者血清vWF和TM水平,保护和修复血管内皮细胞损伤或调节内皮功能紊乱,在减少与预防心脑血管并发症中起到重要作用。 Objective: To investigate the effect of rosuvastatin on serum lipids and serum vWF and thrombin (TM) levels in type 2 diabetic patients. Methods: Eighty patients with type 2 diabetes were randomly divided into observation group and control group. Two groups of patients in the diet adjustment, appropriate physical exercise on the basis of oral hypoglycemic agents or insulin injection therapy. Observation group patients with rosuvastatin tablets 10 mg, po qd, once every 12 weeks. The changes of serum lipid, serum vWF and TM levels and adverse drug reactions were compared between the two groups before and after treatment. Results: The levels of total cholesterol, triglyceride and low density lipoprotein cholesterol (LDL-C) decreased to some extent in the observation group after 12 weeks of treatment. The level of high-density lipoprotein cholesterol (HDL-C) (P <0.05). However, the levels of TC, TG, LDL-C and HDL-C in the control group did not change significantly before and after treatment (P> 0.05). The serum levels of vWF and TM decreased in both groups (P < 0.05 or 0.01), and the observation group decreased more significantly than the control group (P <0.05). Two groups of patients treated with no obvious adverse drug reactions. Conclusion: Rosuvastatin can regulate blood lipid metabolism in patients with type 2 diabetes, which is safe and can reduce serum vWF and TM levels, protect and repair vascular endothelial cell injury or regulate endothelial dysfunction, reduce the risk of heart failure Cerebrovascular complications play an important role.
其他文献
1992年,《药物流行病学杂志》在武汉创刊,至今已整整25年。二十余载砥砺前行,我国医药卫生事业的迅猛发展极大地丰富了我国药物流行病学的内涵,药物流行病学已发展成为一门涵
期刊
@@
目的:探讨阿托伐他汀对慢性阻塞性肺病(COPD)患者血浆炎症细胞因子的影响及疗效.方法:80例COPD住院患者分为观察组和对照组各40例,对照组予吸氧、抗感染、止咳化痰及平喘等常
目的:系统评价类风湿关节炎(RA)患者肿瘤坏死因子(TNF)-α基因启动子区域-308 G/A单核苷酸多态性与TNF-α抑制药治疗有效性的关系.方法:计算机检索PubMed、Embase、The Cochr
Hydroxylammonium nitrate(HAN) is a major constituent in a class of liquid monopropellants and is extensively used in nuclear industry and space propulsion.Previ
目的:观察瑞舒伐他汀辅助治疗阵发性房颤的疗效及对患者血浆超敏-C反应蛋白(hs-CRP)和肿瘤坏死因子-α(TNF-α)水平的影响.方法:90例阵发性心房颤动患者随机分为观察组及对照
目的:探讨小细胞肺癌组织中羧酸酯酶-2(CES-2)和拓扑异构酶1(topo1)的表达对伊立替康(CPT-11)联合铂类化疗预后的临床意义。方法:分别应用免疫组化方法和酶联免疫吸附方法检
目的:系统评价不同剂量(2.5,5,10,15,20 mg·d-1)沃替西汀治疗成人重度抑郁症(MDD)的有效性和安全性.方法:计算机检索PubMed、the Cochrane Library、Web of Science、Embase
目的:观察沙库巴曲缬沙坦钠片治疗扩张型心肌病的疗效.方法:52例扩张型心肌病患者随机分为观察组(25例)和对照组(27例),所有患者均给予抗心表常规药物治疗.在此基础上,对照组
每个人在变老的过程中都会发生一些变化,有人会腰围变粗,有的则经常忘记带钥匙。美国有线新闻网撰文指出,学会辨别这些变化有没有严重影响到健康,将给你 Everyone in the pr
目的:观察依达拉奉联合尤瑞克林治疗急性脑梗死的疗效,以及对患者C反应蛋白(CRP)、神经功能缺损评分(NIHSS)的影响。方法:88例急性脑梗死患者随机分为观察组和对照组。对照组